Loading...
OTCM
VRSEF
Market cap80kUSD
Nov 21, Last price  
0.00USD
Name

Verisante Technology Inc

Chart & Performance

D1W1MN
OTCM:VRSEF chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
35.32%
Rev. gr., 5y
-55.71%
Revenues
0k
030,45911,4092,2490775,300218,816139,00926,40000000
Net income
-115k
L+26.78%
-885,118-861,762-1,484,602-3,551,003-3,510,756-4,896,112-3,233,406-2,389,571-1,641,585-43,963-192,2521,201,589-90,525-114,767
CFO
-28k
L-74.75%
-855,856-734,480-932,458-1,916,408-3,027,507-3,428,797-1,388,479-720,888-338,443000-110,731-27,962

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. The company was incorporated in 2006 and is based in Vancouver, Canada.
IPO date
Dec 09, 2009
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT